Overall, these findings support the hypothesis that genetic variation in IL-10 and NOS3 may modulate susceptibility and disease severity in affected newborns, suggesting potential functional implications relevant to neonatal RDS. The gene discussed is IL10; the disease is newborn respiratory distress syndrome.